Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Cancer Hospital Chinese Academy Of Medical Science, Shenzhen Center

Clinical trials sponsored by Cancer Hospital Chinese Academy Of Medical Science, Shenzhen Center, explained in plain language.

Not yet recruiting 1

Custom mRNA vaccine takes on Hard-to-Treat cancers in early trial

Disease control Not yet recruiting

This early-phase study tests a personalized mRNA vaccine (RH125) in 36 adults with advanced solid tumors that have not responded to standard treatments. The vaccine is designed to train the immune system to attack each patient's unique cancer. Researchers will check safety, immun…

Phase: EARLY_PHASE1 • Sponsor: Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center • Aim: Disease control

Last updated May 11, 2026 20:41 UTC